Novel Gene Panel Predicts Who Can Skip RT in Early Breast Cancer Novel Gene Panel Predicts Who Can Skip RT in Early Breast Cancer

A novel 16-gene panel can both identify patients with a low risk of recurrence if they were to skip postsurgery radiation therapy, and predict which patients would be unlikely to benefit.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news